reason report
reward pt
bottom line reiter consensu estim rais
pt increas convict favor risk-
reward group nt fear flu acceler
cost trend overblown cfo john gallina reiter
bp cost trend acceler primarili driven awp rx
inflat conserv guidanc fulli insur price remain
ration view ci op /esrx mp valid decis
bring pbm in-hous offer opportun ingeniorx
util pbm build-out remain track run-rat ep upsid
top-lin growth expect acceler across
medicaid sever new contract underway medicar advantag
industri growth organ sell season geograph
expans group tuck-in bp margin expans
commerci employ meaning market share gain
local market execut brand pbm unit cost advantag
specialti penetr ceo gail boudreaux creat
new multi-payor diversifi busi servic divis futur
util leadership chang unlock power local market share
provid relationship bcb platform announc capit
posit strong deploy parent cash debt cap
ratio obviou us larg deal like
strateg respons time price-to-earnings consensu
ep ep attract beat rais
contract win accret tuck-in price-to-earnings expans
drive upsid month
host set c-suit manag team meet
includ inform cocktail hour around antm indi hq
host ir team energi optim manag
palpabl everyon charg realiz potenti
pbm separ stand-alon busi
unit report evp brian report directli ceo
drive account flawless execut top
organiz prioriti toward drug cost save
mr griffin view ci-esrx merger valid antm strategi
bring pbm in-hous bullish combin
medic pharmaci capabl offer margin upsid
guidanc estim see attract market
share gain drug cost save pass onto
employ custom lesser extent ma/part also
see ci/esrx merger drive opportun make
ingeniorx pbm choic nfp blue given stand-
alon option scale directli compet nfp
compani inform leerink partner llc research
oper revenu billion number may add total due round
adjust ep number may add total due round
net debt total capit
price-to-earnings lt ep growth
price-to-earnings ep
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
medicar advantag mm member offer attract
top-lin growth pois margin expans bp
latter expect mark russo head
medicar lead segment organiz turnaround
robust growth retail membership pois outsiz growth
share gain membership geograph expans
group age-in program continu tuck-in
acquisit channel check suggest
acquir choic recent deal target inorgan growth
manag medicaid across legaci wlp agp acquisit
remain best-in-class platform meaning membership
gain new contract nc mn ky
pois addit share gain incumb exist
reprocur fl tx plu tund sotund new
head medicaid organ shepherd compani
activ round state contract rfp award iowa rate updat
drive move back normal margin addit rate
increas juli pois final move state profit growth
bid nc mn jointli nfp bcb combin
capabl network state polici influenc local
keen focu social determin underpin antm
approach servic vulner popul also
remain optimist red purpl state va like
expand medicaid new state waiver flexibl around work
requir offer trump administr
market share gain group fulli insur commerci market
key strateg prioriti heretofor
commun clearli street anticip gail
boudreaux vast experi across uhc bcb il aet
drive organiz imper turbo-charg market share
superior local market execut brand
impend pbm cost advantag peter haytaian head
govern busi rotat head
commerci specialti bring long career experi across
oxford agp spearhead effort boost market share
averag commerci group fulli insur book
new diversifi busi servic divis built aim
radiolog caremor extensivist clinic model creat
mini-optum leadership craig samitt
transit role chief clinic offic servic
offer payor agnost across pois util
ingeniorx pbm third leg stool caremor
sachin jain leadership optim retail extensivist model
care coordin complex popul clinic state
antm leadership intent leverag primari care physician
provid network valu base risk contract imper
purchas pcp also acceler uptak telemedicin
 health complement retail clinic set tailor segment
need
reiter consensu estim rais pt
increas convict antm favor risk-reward group
nt fear flu acceler cost trend overblown cfo john gallina
reiter bp cost trend acceler primarili driven awp rx inflat
conserv guidanc fulli insur price remain ration
view ci/esrx valid decis bring pbm in-hous offer
opportun ingeniorx util pbm build-out remain track run-rat ep
upsid
top-lin growth expect acceler across medicaid sever new contract
underway medicar advantag industri growth organ sell season
geograph expans group tuck-in bp margin expans commerci
employ meaning market share gain local market execut brand
pbm unit cost advantag specialti penetr
ceo gail boudreaux creat new multi-payor diversifi busi servic divis
futur util leadership chang unlock power local market share provid
relationship bcb platform announc
capit posit strong deploy parent cash debt cap ratio
obviou us larg deal like strateg respons time price-to-earnings
consensu ep ep attract beat rais contract
win accret tuck-in price-to-earnings expans drive upsid
kaiser compani report leerink partner llc research estim
host set c-suit extend manag team meet includ inform
cocktail hour around indi hq host ir team doug simpson
feest dawn mehring
energi optim manag palpabl everyon charg realiz
potenti differenti though still under-manag asset
host meet execut manag indianapoli headquart
announc organiz chang includ leadership rotat support
strateg aspir drive account execut
specif pbm ingeniorx separ busi unit led
current evp presid commerci specialti busi brian griffin report
directli gail boudreaux
commerci specialti busi led pete haytaian success
tour duti evp presid govern busi mr haytaian charg
task drive increas share gain commerci segment particularli
group fulli insur risk busi enjoy averag market share
despit best local market share also cross shield brand improv local
market execut coordin center leverag effici drive systemat
panel amgail boudreaux presid ceojohn gallina evp cfopanel ampet haytaian evp presid govern busi divisionscott anglin svp cfo govern busi divisiontund sotund presid medicaidmarc russo presid medicarepanel pm pmbrian griffin evp presid commerci specialti busi divisionjeff plant svp cfo commerci specialti busi divisionpatrick blair svp commerci busi segment chief market officerpanel pm pmcraig samitt md evp chief clinic officersachin jain presid caremoregloria mccarthi evp chief administr offic inc
price decis key lever use regard also pbm unit cost
advantag expect ms boudreaux fort lead commerci oper across
organ aet ceo bcb il recent ceo uhc offer
strong direct top endeavor also see key leadership develop
opportun round skill set mr haytaian success turn around
activ recruit senior leader head govern busi
departur pete haytaian commerci segment tund sotund come
extens experi formerli agp presid medicaid
shepherd period intens state rfp contract activ across multipl re-
procur well new contract applic award mark russo continu
success lead medicar advantag busi doug simpson vice-president ir becom cfo
govern busi divis
order realiz aspir multi-payor care deliveri technolog
servic provid era technolog value-bas care also creat
diversifi busi servic segment built two pillar caremor extensivist
retail clinic model aim radiolog benefit manag divis led craig
samitt current evp chief clinic offic vacanc also recruit
senior leadership replac sachin jain success turn around caremor sinc
acquisit report mr samitt along gloria mccarthi chief
treasur chief invest offic role fill scott anglin current svp
announc manag chang meet improv cultur speed market
new roleindividualcurr rolepbm ceobrian griffinpresid commerci specialtyhead commerci specialtypet haytaianpresid govern businesspresid medicaidtund sotunderegion medicaid presidenthead diversifi businesscraig samittchief clinic officertreasur chief invest officerscott anglincfo govern businesscfo govern divisiondoug simpsonvp ir inc
ep guidanc clearli conserv consensu estim offer
discuss would suggest near-term fear flu acceler cost trend
overblown cfo john gallina reiter bp cost trend acceler
primarili driven awp rx inflat flu headwind incorpor
conserv guidanc fulli insur price environ remain ration estim
bp sever flu headwind gener consist cfo
guidanc estim conserv upsid
leerink consensu adjust fund membership insur membership membership revenu expens invest incom expens share count guidanc inc
top prioriti pbm build-out remain track substanti margin expans
pbm busi ep upsid pois run-rat
pbm separ stand-alon busi unit head brian griffin
report directli ceo drive account flawless execut top
pbm build-out top prioriti estim pbm save ingeniorx run-rat
ep ye
success build-out ingeniorx realiz drug save top
organiz prioriti ingeniorx also offer promis util
brian griffin view ci-esrx merger valid compani strategi bring
pbm in-hous bullish combin medic pharmaci capabl
offer margin upsid guidanc estim see attract market
share gain drug cost save pass onto employ custom
lesser extent ma/part
also see ci/esrx merger drive opportun ingeniorx pbm
choic nfp blue given stand-alon pbm option scale
consumm last marriag antm pbm view less riski nfp blue
contract aet-cv ci-esrx unh-optum rx given directli compet
nfp brethren either commerci medicaid
even believ creat valu prime client prime
therapeut investor client addit dozen plan investor
could target ingeniorx
first foremost think ingenio contract quit frankli great valu creator us share open comment abil deliv greater billion gross save pre-tax basi incur sharehold realli incred opportun us combin opportun improv integr medic pharmaci offer new pbm ingeniorx uniqu opportun deliv highli innov product offer market continu expect new pbm deliv least billion gross pharmaceut save run-rat basi migrat enrol new platform januari gail boudreaux presid ceo director inc con call vision ingenio realli becom util within system well interest regard alreadi develop think build platform realli meet need plan see great new opportun execut strategi alreadi made signific progress term drive improv valu term new formulari design well new network strategi continu focu us launch ingenio broadli brian evp president-commerci specialti busi inc con call inc
integr medic pharmaci data poc seen drive improv outcom
valid announc ci-esrx merger
manag assert capabl deliv po rebat
employ custom long time employ liberti determin
would like share drug manufactur rebat worker form lower
premium po discount see rebat fulli insur market need
embed forward price
view arms-length enabl build-out ingeniorx seek
bring pbm ip larg in-hous
contract also provid best-in-class drug purchas scale abl
captur cog econom mail order specialti effici capit without
invest brick motor
dedic team align incent drive implement contract
firewal allow emb ip within pbm platform end-to-end member
experi also retain full formulari control within contract could includ
narrow network previous offer agnost order fulfil across
mail retail also across variou retail pharmaci
medicar advantag mm member offer attract top-lin growth
also pois margin expans bp latter
mark russo head medicar organ remain key leader move segment
organiz turnaround robust growth retail membership pois outsiz organ
growth share gain sell season membership
geograph expans group age-in program continu tuck-in
acquisit channel check suggest acquir choic
recent deal target inorgan growth offer plan outsid state
amerigroup brand ia nj tx current small medicar part presenc
seen enjoy potenti rapid growth build-out ingeniorx pbm
antm assert perceiv acquir choic tuck-in plan
corrobor channel check cultur decentr revers integr
acquir asset view sourc talent seen attract plan
appear tuck-in vein health sun america first choic like
pete haytaian offer color antm margin outlook potenti expand margin
mid-point rang upper end rang particular rate
notic view broadli favor delay hipf tax tailwind
drive margin expans though impress ep may also
upsid driver continu defend hard-won rate top prioriti
healthsun choic member incom impact pre-tax margin accret inc
manag medicaid across legaci wlp agp acquisit remain best-in-class
platform meaning membership gain new contract nc mn ky
compani pois addit share gain incumb exist
reprocur state fl itn region tx plu
tund sotund new head medicaid organ effect shepherd
compani activ round state contract rfp award bid nc mn
conduct jointli nfp bcb combin capabl network state
polici influenc local keen focu social determin underpin antm
approach servic vulner popul
medicaid continu enjoy membership growth solid procur pipelin
sinc best-in-class win rate pipelin medicaid
expans assum pipelin optimist virginia may consid medicaid
expans pleas chip extens perman author
upcom medicaid rfp repres mm new live opportun compani
allianc jv health system provid tremend opportun
allianc associ provid tx co live ar live
allianc structur differ rang partnership true jv la
believ contribut allianc effici deploy capit resourc
abl leverag brand leverag market knowledg provid relationship
allianc allow risk often split antm partner
state/ contractcontract typecontract award daterfp released/ releas dateestim beneficiariesmco coverag incumbentsvirginia medallion arizona acut care/crsre-procurementmarch wcg new mexicore-procurementmarch bcb nm presbyteriankansa kancarere-procurementjun north carolinanewseptemb medicaidre-procurementtbdsumm wcg aetflorida ltcre-procurementtbdsumm aet texa cinew sensewashington remain region re-procurementprior re-procurementopportun region exclud north central southwest rsa anthem inc
compani alreadi announc collabor shield nc upcom north carolina
report perform bp better margin averag given superior
care manag abil leverag cross shield network brand
iowa rate updat drive move back normal margin addit rate
increas juli pois final move state profit growth see progress
rate juli june addit progress expect
state rate claw-back seen littl meaning activ outsid state ny
optimist tailwind tax reform legisl after-tax margin may retain
industri particular state seen challeng offer select claw-back
for-profit player ny budget propos claw-back tax reform delta for-
profit tax excess reserv plan includ not-for-profit ny propos
yet adopt state legislatur
market share gain group fulli insur commerci market key strateg
prioriti commun street clearli far know prior
meet
anticip gail boudreaux vast experi across uhc bcb il aet
drive organiz imper turbo-charg market share superior local
market execut brand impend pbm cost advantag peter haytaian head
govern busi rotat head commerci specialti
bring long career experi across oxford agp spearhead effort
boost market share averag commerci group fulli insur book
jeff plant svp cfo commerci patrick blain svp commerci busi segment
chief market offic also offer import color effort around commerci market
share gain success go-to-market strategi across pbm medic busi
lever drive superior servic drive share gain includ product standard
manag account distribut sale effect standard speed
segment orient allow respons local need also balanc
avail economi scale
increas specialti penetr also remain key prioriti drive increas
share wallet commerci membership across dental vision behavior ancillari
servic offer leverag nation account larg group busi grow
specialti dental vision life stop-loss product specialti penetr
rang manag believ opportun improv dental
vision grow around year
new diversifi busi servic divis built aim radiolog caremor
extensivist clinic model creat mini-optum leadership craig
samitt transit role chief clinic offic
servic offer payor agnost across pois util
ingeniorx pbm third leg stool though current maintain separ
divis ensur account execut build-out opportun time look
offer new color re-organ segment though diversifi busi servic
divis view earli stage time
antm leadership intent leverag strong leverag primari care physician
provid commun integr risk value-bas care contract see
imper purchas primari care physician simultan compani also acceler
uptak telemedicin health complement retail clinic set tailor
segment need
caremor sachin jain leadership optim retail extensivist model care
coordin complex popul model success lower lo
day meaning save per admiss caremor expand dual full
primari care high risk patient expect expand presenc next year caremor
revenu clinic state june
caremor extensivist model emerg element government busi
challeng acquisit
aim rbm serv plan today rapidli build capabl
manag note aim largest competitor esrx-own evercor ci
acquisit could present new opportun growth
evp chief administr offic gloria mccarthi highlight
migrat system modern system well implement agil
develop approach take comprehens look modern bill rate
desktop capabl
capit posit strong deploy parent cash ratio
debt cap ratio trade attract price-to-earnings consensu
ep ep focu remain tuck-in deal
capabl obviou us larg deal like time
debt cap increas issuanc new debt offer larg fund heathsun
estim deploy
million sourc compani payment oper payment buy-back cash end compani also remain capac rais current commerci paper program revolv credit facil ratio inc
stock trade attract consensu ep
see earn upsid contract win accret tuck-in multipl
expans drive upsid pt next month new pt
contempl price-to-earnings ep
trade price-to-earnings consensu
inc incom oper expensesbenefit oper invest incom extinguish incom continu incom chang revenu inc
enrol group self group fulli inc
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
multipl expans use absolut rel price-to-earnings multipl base approach valuat
ep estim combin price-to-earnings base approach dcf model point
intrins valu compani plu add premium deal probabl
price target repres price-to-earnings ep
downsid risk invest thesi valuat aet legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn
upsid risk invest thesi valuat aet accret acquisit
aggress share repurchas use solid parent cash posit debt rais
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
new pt contempl price-to-earnings ep
risk invest thesi valuat
legisl regulatori polici chang could either dis-intermedi
insur us benefit marketplac place unforeseen top-lin margin
headwind commerci medicar advantag medicaid dual elig book
not-for-profit health insur price irrat commerci health benefit
acceler employ exit sponsorship health benefit us
marketplac post implement afford act
advers select public exchang protect adequ given delay
true-up govern payment
acquisit asset without attract return capit investor
organiz and/or oper risk drive execut mis-step downsid risk
earn
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
base price-to-earnings multipl appli stand-alone ep rate ci
outperform price target
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti econom downturn
provid re-up intens servic deliveri cobra acceler uptak
member util care advanc layoff pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz econom downturn
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus
longer term state-bas insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress potenti downsid membership
polit shock lead singl payer
compani specif risk signific declin equiti market could result increas fund
compani pension oblig polit legal oper regulatori econom
risk foreign oper
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans price base case
ep estim
risk valuat includ
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid entitl program
state feder suprem court level also risk consid
remain posit reiter op rate month pt
contempl price-to-earnings ep
risk invest thesi valuat legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn acceler medic cost
trend util improv economi
pt reflect price-to-earnings ep
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid
scale issu result loss specialti rx pharmaci contract
acquisit offer adequ return capit
upsid takeout substanti premium key risk
carve-out behavior health servic current state contract
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
base post month turnaround rate outperform pt
contempl price-to-earnings ep
risk highlight first spike util on-board new state contract
dual elig integr second state-bas insur exchang result advers
select reduc sustain earn power third state-bas contract rate increas
suffici cover medic trend off-set industri fee medicaid premium fourth risk re-
procur exist contract could creat substanti downsid risk volatil fifth
legisl judici risk manag medicaid entitl extrem case singl
payer model also possibl downsid
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
rate outperform price target contempl price-to-earnings
cash ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti double-dip recess
provid re-up intens servic deliveri cobra acceler uptak member util
care advanc lay-off pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz double-dip recess
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus substanti
long-term state base health insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress also potenti downsid membership
risk relat collect industri fee medicar medicaid premium
polit shock lead singl payer
compani specif risk downsid risk price target includ acquisit asset
arena yield adequ return capit
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free yield ratio also inform potenti multipl expans
except low ratio and/or high free yield point potenti greater
base rate wcg outperform pt contempl price-to-earnings
ep
downsid risk price target includ execut new state contract dual elig
award rate increas suffici cover medic trend state clawback tax off-set tax
reform tailwind potenti dial medicaid expans ky upsid risk price
target includ take-out larger player
